GGrantIndex
Sort

78,016 grants matching breast cancer

Discovery, Biology and Risk of Inherited Variants in Breast Cancer

$574,120
David John Hunter · Harvard School Of Public Health · U19 · FY2014 · CA

Medical Care Burden of Cancer: System and Data Issues

$574,102
Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2009 · CA

3-D Computer Modeling for Optimizing Body Image following Breast Reconstruction

$574,081
Mia K Markey · University Of Texas At Austin · R01 · FY2012 · CA

Therapeutic agents targeting nuclear receptor signaling in distinct molecular subtypes of breast cancer

$574,038
Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2022 · CA

Hexokinase 2 and cancer therapy

$574,013
Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA

Case-Control Study of Pancreas Cancer Etiologic Factors

$574,007
Harvey A Risch · Yale University · R01 · FY2008 · CA

A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments

$573,913
David Kevin Wood · University Of Minnesota · R01 · FY2022 · CA

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors

$573,888
Laura Q Rogers · University Of Alabama At Birmingham · R01 · FY2022 · CA

Bionanotechnology approach for treatment of lung cancer

$573,870
Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2022 · CA

Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer

$573,846
H. Steven Wiley · Battelle Pacific Northwest Laboratories · U01 · FY2022 · CA

Moving Forward: A weight loss program for African-American breast cancer survivo

$573,808
Ben Steven Gerber · University Of Illinois At Chicago · R01 · FY2014 · CA

Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer

$573,794
Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA

A HIGHLY SUPERIOR AND SELECTIVE CANCER IMMUNOTHERAPY-BASED APPROACH FOR TRIPLE-NEGATIVE BREAST CANCERS

$573,784
Rector & Visitors Of The University Of Virginia · · FY2018 · Defense Health Agency

PROSPECTIVE STUDY OF HEALTH IN RUNNERS AND WALKERS

$573,778
University Of Calif-Lawrenc Berkeley Lab · R01 · FY2001 · HL

Administrative Core

$573,745
John Pounardjian · Case Western Reserve University · P30 · FY2020 · CA

Predictive experiment-based multiscale models of angiogenesis in breast cancer

$573,724
Aleksander S. Popel · Johns Hopkins University · R01 · FY2011 · CA

Oxidative Stree, Antioxidants and Risk of Breast Cancer: A Prospective Analysis

$573,710
A. Heather Eliassen · Brigham And Women'S Hospital · R01 · FY2010 · CA

NOVEL PRO-INFLAMMATORY PROGESTERONE RECEPTOR/STAT5 GENE PROGRAMS IN BREAST CANCER

$573,667
University Of Kansas Medical Center Research Institute, Inc. · · FY2016 · Department of the Army

San Juan Minority-Based Community Clinical Oncology Program

$573,647
Luis Baez · Municipio De San Juan · U10 · FY2013 · CA

In Vivo Metabolic Catastrophe Is Induced By Acute Oncogene Inhibition (PQ #22)

$573,631
Andrei Goga · University Of California, San Francisco · R01 · FY2013 · CA

Philadelphia Breast Cancer Family Registry

$573,630
Mary Beryl Daly · Fox Chase Cancer Center · U01 · FY2008 · CA

Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV

$573,624
Carolyn Y Fang · Fox Chase Cancer Center · R01 · FY2011 · CA

COCHAPERONE UNC45A: A NOVEL IMMUNOTHERAPEUTIC TARGET TO ERADICATE BREAST CANCER

$573,567
Augusta University Research Institute, Inc · · FY2019 · Defense Health Agency

Development of BRCA1-mimetic drugs for breast cancer

$573,566
Eliot M Rosen · Georgetown University · R01 · FY2012 · CA

Whitlockite nanoparticle-based immunotherapy for bone metastasis

$573,510
Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2019 · CA